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Background Infective endocarditis (IE) secondary to rat-bite fever (RBF) is rare but potentially lethal. Rapid diagnosis is of ut-
most prognostic importance. However, the diagnosis of RBF is challenging because Streptobacillus moniliformis does
not grow under conventional culture conditions.
...................................................................................................................................................................................................
Case summary A 65-year-old male without previous cardiac history presented with sudden onset of balance problems and facial
palsy. For 2 weeks, he had experienced intermittent fever and myalgia. Transoesophageal echocardiography (TOE)
revealed severe mitral and aortic valve IE with aortic root abscess. The patient underwent a double biological valve re-
placement. Blood cultures remained negative after 9 days of incubation. However, sub-cultivation on solid media dem-
onstrated the growth of pleomorphic Gram-negative rods, identified as S. moniliformis. After 4 weeks of antibiotic
therapy, he was discharged. One month later, control TOE showed valve excrescences and aortic annular aneurysm.
Despite comprehensive surgery, antibiotic treatment, and intensive care, the patient died 1 week after reoperation.
...................................................................................................................................................................................................
Discussion A fatal outcome of S. moniliformis IE is rare. The majority of previous cases describe underlying valvular abnormal-
ities or death due to insufficient antimicrobial therapy. Here, the patient had no prehistory of valvular heart disease
and despite appropriate antibiotics, the outcome was fatal. Rapid diagnosis of RBF IE has prognostic implications.
Identification of S. moniliformis is, however, difficult, because the bacterium is fastidious and does not grow under
standard laboratory conditions. Therefore, diagnosis often relies on clinical symptoms or a history of rodent expos-
ure. Close attention to this disease by clinicians, in addition to, dialogue with clinical microbiologists is essential.
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Learning points
• Possible rodent exposure several months before the diagnosis of infective endocarditis (IE) should be thoroughly explored.
• To prevent complications and a delayed diagnosis, collaboration between clinicians and clinical microbiologists is essential to improve
Streptobacillus moniliformis identification as the bacteria cannot be grown under standard laboratory conditions.
• Close follow-up and extension of antibiotic therapy may be considered in patients with severe rat-bite fever IE.
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Streptobacillus moniliformis is the causative pathogen of rat-bite fever
(RBF) in Europe and North America.1 The bacterium is a fastidious
Gram-negative bacillus found as a normal part of the oro- and naso-
pharyngeal microbiota of rats and transmission to humans occurs
through contact with infected rodents.1,2
Rat-bite fever is a rare zoonosis that manifests as an acute systemic
disease. Symptoms are characterized by fever, headache, maculopap-
ular rash, and migratory polyarthritis.1 Reported complications in-
clude meningitis, focal abscesses, and infective endocarditis (IE).3 The
estimated overall mortality rate of untreated RBF is 7–13%.1,4,5
As RBF IE is potentially lethal, the diagnosis of streptobacillosis has
important prognostic implications. However, identification of S. moni-
liformis is challenging as the bacterium does not grow under standard
laboratory conditions. Therefore, diagnosis depends on clinical symp-
toms in combination with a history of relevant exposure. Here, we




A 65-year-old Danish male with a medical history of type 2 diabetes
and hypertension was admitted to the hospital with suspicion of is-
chaemic stroke due to sudden onset of balance problems and facial
palsy. For 2 weeks, the patient had experienced discomfort, intermit-
tent fever, and myalgia. On examination, he was afebrile and vital
parameters were normal. The patient presented no cardiovascular
symptoms, and the cardiovascular examination was normal.
Electrocardiogram showed sinus rhythm and right bundle branch
block (Figure 1).
Blood tests showed a C-reactive protein level of 135 mg/L, haemo-
globin 7.3 mmol/L, and creatinine 141mmol/L, but normal leucocyte
and platelet count of 6.4  109/L and 167  109/L, respectively.
Other laboratory results were also within the normal range.
Magnetic resonance imaging of the brain demonstrated ischaemic
changes involving both the cerebellar hemispheres and the right
frontal lobe (Figure 2). Computed tomography (CT) of the chest, ab-
domen, and pelvis showed a minor splenic abscess and intravenous
cefuroxime 3 g every 8 h was initiated on suspicion of acute cardi-
oembolic cerebral infarction given the manifestations in the brain and
spleen. Six days after admission, a transoesophageal echocardiog-
raphy (TOE) verified severe mitral valve and aortic valve IE with aor-
tic root abscess (Figure 3A, Videos 1 and 2), and the antibiotic therapy
was changed to intravenous meropenem 2 g every 12 h for presumed
blood culture-negative IE (BCNIE). The following day, the patient
underwent double biological valve replacement, debridement, and ir-
rigation of the aortic root abscess.
In total, one blood culture set was obtained prior to the initiation
of antibiotic treatment and two sets after antibiotic administration.
After 9 days of incubation, blood cultures (BD BACTECTM FX)
remained negative, but a sub-cultivation of one primary aerobic bot-
tle onto solid media (10% horse blood agar plates, incubated at 35C
in 5% CO2) was performed and yielded growth of Gram-negative
pleomorphic rods 4 days hereafter. By the use of MALDI TOF-MS
(Biotyper 3.1, Bruker Daltonik, Germany), the bacterium was identi-
fied to species-level as S. moniliformis (log-score 2.410) and whole-
genome-sequencing was performed using the Illumina MiSeq instru-
ment, confirming the isolate as S. moniliformis (data not shown). In
addition, S. moniliformis was detected on both heart valves by 16S
rRNA sequencing. Antimicrobial susceptibility testing was performed
by using Etest (BioMérieux, Marcy l’Etoile, France) according to the
EUCAST pharmacokinetics/pharmacodynamics (non-species
related) breakpoints. The isolate was susceptible to benzylpenicillin
(MIC: 0.016 mg/L) and ceftriaxone (MIC: 0.016 mg/L).
On further questioning after S. moniliformis identification, the pa-
tient recalled having been bitten by rats in several toes 2 months
prior to admission. Intravenous meropenem was later increased to
2 g every 8 h in combination with intravenous gentamicin 3 mg/kg
every 24 h. Administration of gentamicin was terminated after
10 days due to high serum-gentamicin levels (data not shown).
Hereafter treatment was switched to definitive therapy with intra-





admission Rate bite in several toes
Day 1 Admission to hospital.
Day 6 Transoesophageal echocardiography (TOE)
revealed severe infective endocarditis (IE).
Initiation of intravenous meropenem 2 g two
times daily for blood culture-negative IE.
Day 7 Surgical management of IE.
Day 13 Increased meropenem dosage to 2 g three times
daily and the addition of gentamicin 3 mg/kg
(according to Danish guidelines on blood cul-
ture-negative IE).
Day 17 Identification of Streptobacillus moniliformis (by sub-
cultivation).
Day 19 Antibiotic treatment was switched to benzylpenicil-
lin 3 g four times daily plus gentamicin 3 mg/kg.
Day 34 Completion of the antibiotic course. The patient
was discharged without clinical or TOE signs of
infection to a rehabilitation facility.
Day 66 Control TOE revealed valve excrescences, aortic
annular aneurysm, and loosening of the mitral
valve prosthesis.
Administration of benzylpenicillin 3 g four times
daily plus gentamicin 3 mg/kg was initiated.
Day 74 Reoperation.
Day 81 Patient died.





































The post-operative course was complicated by third-degree atrio-
ventricular-block with the need for permanent pacemaker implant-
ation. After 4 weeks of antibiotic treatment, control TOE showed no
pendulous excrescences (Figure 3B), and the patient was discharged.
However, at 1-month follow-up visit a TOE revealed severe valve
excrescences, aortic annular aneurysm, and loosening of the mitral
valve prosthesis (Figure 3C,D). Cardiac CT showed severe tissue de-
struction in the aorto-mitral area (Figure 4). Blood cultures, in add-
ition to, sub-cultivation on solid media were performed, but the
growth of S. moniliformis was not detected. One week later, reopera-
tion was performed including double valve replacement. Post-
operatively, the patient developed biventricular heart failure requir-
ing veno-arterial extracorporeal membrane oxygenation. Despite
comprehensive intensive care, the patient died 1 week post-
operatively.
Discussion
This is the first fatal case of IE caused by S. moniliformis in Denmark,
and to our current knowledge, the first fatal case treated with anti-
microbial agents in Europe. The prevalence of RBF is rare. The dis-
ease may, however, be underdiagnosed due to a lack of information
on rodent contact and presentation of non-species-specific clinical
symptoms.
The prevalence of IE secondary to RBF is rare but uncertain.
Nevertheless, this complication is the best described with a reported
mortality rate as high as 53%.1,5,6 A majority of previous reports have
described underlying cardiac valvular abnormalities, mostly rheumat-
ic, or death as outcome in absence of effective antibiotic therapy or
inadequate antibiotic dosing.1,6–8 In literature, only 26 cases with na-
tive valve RBF IE have been reported.5
Isolation and identification of S. moniliformis from clinical samples
have recently been thoroughly reviewed by Eisenberg et al.9 Sodium
polyanethol sulfonate, an anticoagulant, present in most commercial
Figure 1 Initial electrocardiogram showed sinus rhythm and right bundle branch block.

















































.. blood culture bottles inhibits the growth of S. moniliformis and there-
fore challenges isolation from routine blood cultures.9,10 In addition,
S. moniliformis is a fastidious bacterium requiring microaerophilic
growth conditions and benefits from added CO2 (5–10%). For opti-
mal cultivation, enriched artificial media is preferable.
In the present case, all aerobic and anaerobic blood cultures
remained negative in the BACTECTM FX blood culture system after
14 days of incubation. Due to clinical suspicion of IE, sub-cultivation
was performed in order to detect potentially fastidious microorgan-
isms. This method is described in the 2015 ESC Guidelines for the
management of IE.11 In addition, the guideline proposes a diagnostic
strategy for BCNIE including serological testing as well as rheumatoid
factors and polymerase chain reaction. Several studies have shown
that serological evaluation may aid in diagnosis in BCNIE.12,13
However, no serological tests for RBF are available. A reliable
method for species identification of S. moniliformis is the use of
MALDI TOF-MS.9 16S rRNA gene sequencing can be used, but insuf-
ficient species resolution of 16S rRNA gene sequencing is possible.5,9
Due to the rarity of RBF IE, no treatment guidelines exist.
However, high-dose benzylpenicillin (12 g/day) for 4 weeks in com-
bination with gentamicin for the initial 2 weeks has been recom-
mended.1 Our isolate was fully susceptible to penicillin, and therefore
interpreted as fully susceptible to carbapenem. According to litera-
ture, no in vitro resistance to penicillin has been described.
In the present case, the patient was not known with a prehistory
of valvular heart disease and despite apparent in vitro susceptibility,
treatment failed. The cause of this failure is uncertain. Nevertheless,
Figure 2 Magnetic resonance imaging of the brain (T2 FLAIR)
demonstrated ischaemic changes in the cerebellar hemispheres.
Figure 3 (A) Diagnostic transoesophageal echocardiography revealed severe aortic valve and mitral valve infective endocarditis as well as aortic
root abscess. (B) Transoesophageal echocardiography before discharge showed no pendulous excrescences. (C, D) Control transoesophageal echo-
cardiography 4 weeks after discharge showed severe valve excrescences, aortic annular aneurysm, and loosening of the mitral valve prosthesis.
































































































even though identification of S. moniliformis was successful, the diag-
nosis was delayed due to lack of an exposure history, non-specific
symptoms, and difficulties in culture diagnosis, i.e., lack of growth in
blood cultures under standard conditions. Due to the fatal outcome
presented here, we advocate for a treatment duration of 6 weeks, in
addition to, a closer follow-up regimen.
Conclusion
Given the risk of complications and potential lethal outcomes of RBF,
the diagnosis of streptobacillosis has important prognostic implica-
tions. Identification of S. moniliformis is, however, difficult as the bac-
terium does not grow under standard laboratory conditions.
Therefore, close attention to this disease by clinicians including ex-
posure history in patients with severe IE along with a dialogue with
clinical microbiologists is of utmost importance.
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